tumor lesion in the right parietal region, with the surrounding zone of perifocal oedema. During the operative procedure the tumor was maximally reduced using a microneurosurgical technique. The collected tumor tissue was frozen in liquid nitrogen and transported to the laboratory, where it was immediately frozen at )75°C. The peripheral blood sample was processed immediately.
The local Ethical Committee approved our study and the patient gave her informed consent.
Tumor sample for DNA isolation was the parts of obvious tumor mass (evaluated by neurosurgeon and based on macroscopic appearance and tissue color, density, and consistency on gross section). The sample was also evaluated for the percentage of tumor cells by pathologist and consisted of more than 80% of tumor cells. Approximately 0.5 g of tumor tissue was homogenized with 1 ml extraction buffer (10 mM Tris-HCl, pH 8.0; 0.1 M EDTA, pH 8.0; 0.5% sodium dodecyl sulfate) and incubated with proteinase K (100 lg/ml; Sigma, USA; overnight at 37°C). Phenol chloroform extraction and ethanol precipitation followed.
Blood sample was used to extract lymphocyte DNA. Five ml of blood was lysed with 7 ml distilled water and centrifuged (15 min/5000 g). The pellet was then processed as for DNA extraction from the tissue samples.
The optimal polymerase chain reaction (PCR) mixture (25 ll) for APC's exon 11 amplification was: 20 pmol of each primer (5¢-GGACTACAGGCCATTGCAGAA-3¢ and 5¢-GGCTACATCTCCAAAAGTCAA-3¢), 200 lM of each dNTP, 200-400 ng template DNA, 1 ll (0.5 U) of Taq polymerase, 1 mM MgCl 2 , 5 ll 10Âreaction buffer II (500 mM KCl, 100 mM Tris-HCl, pH 8.3). PCR conditions were: initial denaturation, 4 min/95°C; denaturation, 1 min/94°C; annealing, 2 min/58°C; extension, 1.5 min/72°C; 35 cycles. The PCR products were analyzed on 2% agarose gels.
Loss of heterozygosity (LOH) of the APC gene was detected on the basis of restriction fragment length polymorphism (RFLP) of the PCR products. A Rsa I polymorphic site in exon 11 was investigated. PCR amplification of exon 11 generated a 133-bp fragment that is cleaved to 85-and 48-bp fragments by Rsa I restriction if the polymorphic site is present, and remains uncleaved if the site is absent. PCR aliquots (10-15 ll) were digested with 6 U Rsa I (Gibco, USA; 12 h at 37°C) and were electrophoresed on 15% polyacrylamide gels and on Spreadex EL 300 gels (Elchrom scientific, Switzerland), stained with SyberGold (Molecular Probes, Netherlands). LOH/Rsa I was demonstrated only in informative (heterozygous) persons when the tumor DNA showed loss of either the single uncut band (133 bp) or of the two cut bands (85 + 48 bp) compared to autologous blood DNA.
The histopathological diagnosis of oligoastrocytoma was based on recognition of two different glial components both of which are unequivocally neoplastic which is shown in Figure 1 . Immunohistological analysis revealed strong reactivity to glial fibrillary acidic protein (GFAP) in astocytic areas of differentiation while zones with oligodendroglial differentiation contain predominantly GFAP negative cells.
The analysis of Rsa I polymorphic site in APC's exon 11 of our proband's blood sample showed that the patient was heterozygous for this polymorphism. Moreover, the oligoastrocytoma sample demonstrated LOH when compared to the patient's constitutive DNA as shown on Figure 2 . We performed analysis on Spreadex gel and confirmed it on 13% polyacrylamide gel stained with silver. This finding led us to conclude that our sample comprised gross deletion of the APC gene.
The mechanisms of brain tumor initiation and progression have not yet been completely investigated and elucidated. As with other tumors, the formation of brain tumors is the result of multiple consecutive genetic changes that represent a critical factor in tumor evolution [8] . No consistent genetic abnormalities have been detected that would indicate the genetic profile of oligoastrocytomas [9, 10] . Our result offers APC tumor suppressor gene as a potential candidate involved in development of oligoastrocytoma. We consider our finding a small but relevant contribution to understanding pathophysiological mechanisms of brain tumor formation.
Further investigation regarding this gene on a bigger sample should be performed in future to confirm our suggestion. 
